Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

The survival benefits of adjuvant radiotherapy for malignant meningioma: a retrospective cohort study

Universa Medicina · Vol. 44 No. 3 (2025) · hlm. 318–327

DOI
10.18051/UnivMed.2025.v44.318-327
ISSN
2407-2230, 1907-3062
Terbit
2025-11-27
Penerbit
Faculty of Medicine, Universitas Trisakti
Bahasa
eng
Lisensi
creativecommons.org/licenses/by-nc-sa/4.0

Abstrak

BackgroundMalignant meningiomas (MM) are rare aggressive tumors associated with poor survival outcomes. Due to their rarity, there is limited data on the outcomes and prognostic factors of MM patients, particularly on adjuvant radiotherapy roles in this tumor population. This study aims to investigate the clinical characteristics, prognostic factors, and survival outcomes of MM with focus on survival benefits of adjuvant radiotherapy. MethodsThis retrospective cohort study analyzed 19 MM patients, who were initially subjected to postoperative radiotherapy, at Dr. Kariadi General Hospital, Semarang, from 2013 to 2023. Kaplan-Meier analysis was used to estimate survival rates at 1, 2, and 5 years. Univariate and multivariate Cox regression analyses were performed to identify factors associated with overall survival (OS). Variables with a p-value ≤ 0.25 in univariate analysis were included in the multivariate models. ResultsThe median OS was 16 months (95% CI 0.0–40.2), with estimated 1-year, 2-year, and 5-year survival rates of 52.6%, 42.1%, and 15.8%, respectively. Adjuvant radiotherapy (RDT) was associated with a significantly improved OS (p<0.001). However, sex, age, tumor location, and extent of resection did not show a significant association with OS. Cox regression showed that RDT had no statistically significant effect on OS in the multivariate model (HR = 0, 95% CI 0–1.8, p=0.923). ConclusionAdjuvant radiotherapy is critical for improving OS in MM patients, and gross-total resection (GTR) alone does not guarantee better long-term outcomes. Further studies with larger cohorts and molecular analysis are necessary to refine treatment strategies for MM.

Kata kunci

Jaringan kolaborasi para penulis

15 penulis · 46 tautan kepenulisan bersama

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Diponegoro University
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Tjia Siauw JanAfiliasi tidak diketahui1
Dewi Kania SugihartiAfiliasi tidak diketahui1
Fatinah ShahabAfiliasi tidak diketahui1
Tania Tedjo MinuljoAfiliasi tidak diketahui1
Calvin Layuk AlloAfiliasi tidak diketahui1
Mahayu Dewi ArianiAfiliasi tidak diketahui1
Sultana FaradzAfiliasi tidak diketahui1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) https://univmed.org/ejurnal/index.php/medicina/oai, pertama di-harvest 10 Nov 2026, terakhir terlihat 16 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">The survival benefits of adjuvant radiotherapy for malignant meningioma: a retrospective cohort study</dc:title>
	<dc:creator xml:lang="en">Bakhtiar, Yuriz</dc:creator>
	<dc:creator xml:lang="en">Eka Setiawan, Fariz</dc:creator>
	<dc:creator xml:lang="en">Ilmansyah, Rafi</dc:creator>
	<dc:creator xml:lang="en">Prihastomo, Krisna Tsaniadi </dc:creator>
	<dc:creator xml:lang="en">Priambada, Dody </dc:creator>
	<dc:creator xml:lang="en">Rizky Aryani Septarina, Faiza </dc:creator>
	<dc:creator xml:lang="en">Arifin, Muhamad Thohar </dc:creator>
	<dc:creator xml:lang="en"> Muttaqin, Zainal</dc:creator>
	<dc:subject xml:lang="en">Adjuvant radiotherapy</dc:subject>
	<dc:subject xml:lang="en">malignant meningioma</dc:subject>
	<dc:subject xml:lang="en">prognostic factor</dc:subject>
	<dc:subject xml:lang="en">survival outcome</dc:subject>
	<dc:description xml:lang="en">BackgroundMalignant meningiomas (MM) are rare aggressive tumors associated with poor survival outcomes. Due to their rarity, there is limited data on the outcomes and prognostic factors of MM patients, particularly on adjuvant radiotherapy roles in this tumor population. This study aims to investigate the clinical characteristics, prognostic factors, and survival outcomes of MM with focus on survival benefits of adjuvant radiotherapy.
MethodsThis retrospective cohort study analyzed 19 MM patients, who were initially subjected to postoperative radiotherapy, at Dr. Kariadi General Hospital, Semarang, from 2013 to 2023. Kaplan-Meier analysis was used to estimate survival rates at 1, 2, and 5 years. Univariate and multivariate Cox regression analyses were performed to identify factors associated with overall survival (OS). Variables with a p-value ≤ 0.25 in univariate analysis were included in the multivariate models.
ResultsThe median OS was 16 months (95% CI 0.0–40.2), with estimated 1-year, 2-year, and 5-year survival rates of 52.6%, 42.1%, and 15.8%, respectively. Adjuvant radiotherapy (RDT) was associated with a significantly improved OS (p&amp;lt;0.001). However, sex, age, tumor location, and extent of resection did not show a significant association with OS. Cox regression showed that RDT had no statistically significant effect on OS in the multivariate model (HR = 0, 95% CI 0–1.8, p=0.923).
ConclusionAdjuvant radiotherapy is critical for improving OS in MM patients, and gross-total resection (GTR) alone does not guarantee better long-term outcomes. Further studies with larger cohorts and molecular analysis are necessary to refine treatment strategies for MM.</dc:description>
	<dc:publisher xml:lang="en">Faculty of Medicine, Universitas Trisakti</dc:publisher>
	<dc:date>2025-11-27</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://univmed.org/ejurnal/index.php/medicina/article/view/1761</dc:identifier>
	<dc:identifier>10.18051/UnivMed.2025.v44.318-327</dc:identifier>
	<dc:source xml:lang="en">Universa Medicina; Vol. 44 No. 3 (2025); 318-327</dc:source>
	<dc:source>2407-2230</dc:source>
	<dc:source>1907-3062</dc:source>
	<dc:source>10.18051/UnivMed.2025.v44.i3</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://univmed.org/ejurnal/index.php/medicina/article/view/1761/843</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 2025 Yuriz Bakhtiar, Fariz Eka Setiawan, Rafi Ilmansyah, Krisna Tsaniadi  Prihastomo, Dody  Priambada, Faiza  Rizky Aryani Septarina, Muhamad Thohar  Arifin, Zainal  Muttaqin</dc:rights>
	<dc:rights xml:lang="en">https://creativecommons.org/licenses/by-nc-sa/4.0</dc:rights>
</oai_dc:dc>